Nanoparticles permeate lungs to deliver pulmonary drugs

Researchers from Johns Hopkins University have developed nanoparticles that can shuttle chemicals through the thick mucus membranes of pulmonary airways to deliver drugs. The team’s work was published in the journal Science Advances.  Traditional therapies for cystic fibrosis, COPD and asthma include inhaled corticosteroids that adhere to the walls of air passages. Thick mucus tends to build up inside such passageways, creating a challenge for any delivery system. Get the full story at our sister site, Drug Delivery Business News. The post Nanoparticles permeate lungs to deliver pulmonary drugs appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Pharmaceuticals Research & Development Respiratory Johns Hopkins Source Type: news